Evaluating the Care Burden of Caregivers of Patients With Brain Injury and Determining the Influencing Factors
NCT ID: NCT04936360
Last Updated: 2021-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2021-04-15
2021-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
İnvestigators also will record the type of caregiving (family member or paid professional) and socio-demographic characteristics of the caregivers . Sleep quality will be determined with Pittsburgh Sleep Quality İndex (PSQI), quality of life with NHP (Nottingham Health Profile), level and risk of anxiety and depression with Hospital Anxiety and Depression Scale, satisfaction level with The Satisfaction with Life Scale , care burden with Caregiver Strain Index (CSI).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Group
Patients with non-progressive non-neurodegenerative acquired brain damage, who were over 18 years of age, who could establish voluntary social communication will be included in the study.
questionnaires for clinical assessments
questionnaires for clinical assessments
Caregivers Group
Caregivers over the age of 18, who took care of the patient for at least 1 month, and who did not have premorbid medical or psychological problems will be included in the study.
questionnaires for clinical assessments
questionnaires for clinical assessments
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaires for clinical assessments
questionnaires for clinical assessments
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to read or understand the questionnaire
* at least 18 years of age
* primary caregiver of a patient diagnosed with acquired brain injury
* at least 18 years of age
* had provided care for at least one month
* providing care to the patient for more than 4 h per day
* did not have any major premorbid medical and psychological illnesses
* able to read or understand the questionnaire
Exclusion Criteria
* inability to read and understand questions.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasin Demir
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatma Özcan, MD
Role: PRINCIPAL_INVESTIGATOR
Gaziler Physical Medicine and Rehabilitation, Training and Research Hospital, Department of PMR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fatma Özcan
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16
Identifier Type: -
Identifier Source: org_study_id